Pieris Pharmaceuticals Inc (PIRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PIRS | AZN | AMGN | GILD | VRTX |
| Company | Pieris Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 15.01 | 92.25 | 328.69 | 123.24 | 451.75 |
| High | 15.35 | 92.48 | 329.50 | 123.60 | 455.92 |
| Low | 13.26 | 91.95 | 327.21 | 122.38 | 451.75 |
| Latest | 13.60 | 92.21 | 327.85 | 123.03 | 454.81 |
| Change | -2.53 | -0.30 | -0.84 | -0.15 | +1.07 |
| % Change | -15.69% | -0.32% | -0.26% | -0.12% | +0.24% |
| Volume | 51,700 | 1,161,866 | 540,240 | 1,151,740 | 239,584 |
| 20-Day Average Volume | 21,120 | 4,817,683 | 2,925,379 | 6,657,426 | 1,287,477 |
| Previous Close | 16.13 | 92.51 | 328.69 | 123.18 | 453.74 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.22 | 91.23 | 327.34 | 122.54 | 453.75 |
| 20-Day Raw Stochastic | 8.29% | 72.91% | 45.34% | 52.81% | 68.01% |
| 20-Day Relative Strength | 32.62 | 58.12 | 52.38 | 50.96 | 56.57 |
| Weighted Alpha | -50.53 | +41.27 | +24.79 | +30.77 | +11.54 |
| Today's Opinion | 32% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 8% Buy | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.72% since 12/06/24 | -0.08% since 12/23/25 | -1.11% since 12/23/25 | -1.71% since 12/23/25 | -1.00% since 12/23/25 |
| Low | 13.26 on 12/13/24 | 91.99 on 12/31/25 | 325.83 on 12/30/25 | 122.41 on 12/31/25 | 451.75 on 12/31/25 |
| High | 17.36 on 12/10/24 | 92.91 on 12/26/25 | 334.38 on 12/24/25 | 126.25 on 12/24/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | -15.53% since 11/13/24 | -0.71% since 11/28/25 | -5.11% since 11/28/25 | -2.22% since 11/28/25 | +4.85% since 11/28/25 |
| Low | 13.26 on 12/13/24 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 17.36 on 12/10/24 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | -18.42% since 09/13/24 | +20.00% since 09/30/25 | +16.16% since 09/30/25 | +10.86% since 09/30/25 | +16.09% since 09/30/25 |
| Low | 13.26 on 12/13/24 | 80.48 on 11/04/25 | 283.00 on 10/01/25 | 108.46 on 10/02/25 | 392.49 on 10/01/25 |
| High | 17.70 on 11/06/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | +36.00% since 06/13/24 | +31.75% since 06/30/25 | +17.40% since 06/30/25 | +10.99% since 06/30/25 | +2.12% since 06/30/25 |
| Low | 6.20 on 07/12/24 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 18.68 on 08/26/24 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,955 | 286,915,328 | 176,993,312 | 152,826,976 | 115,122,448 |
| Shares Outstanding, K | 1,320 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 42,810,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -24,540,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -3,590,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.61 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.19 on 11/13/24 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 04/04/25 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.25 | 15.07 | 15.25 | 30.03 |